Your browser doesn't support javascript.
loading
Everolimus for Treating Hormone Receptor-positive Metastatic Breast Cancer Previously Treated With Cyclin-dependent Kinase 4/6 Inhibitors.
Kitano, Sae; Honda, Akiko; Itoi, Naoko; Lee, Tecchuu.
Affiliation
  • Kitano S; Department of Breast Surgery, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan skitano@koto.kpu-m.ac.jp.
  • Honda A; Department of Breast Surgery, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
  • Itoi N; Department of Breast Surgery, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
  • Lee T; Department of Breast Surgery, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
Anticancer Res ; 42(8): 3913-3919, 2022 Aug.
Article in En | MEDLINE | ID: mdl-35896230
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Protein Kinase Inhibitors / Everolimus Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Anticancer Res Year: 2022 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Protein Kinase Inhibitors / Everolimus Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Anticancer Res Year: 2022 Document type: Article Affiliation country: